4//SEC Filing
Olefson Jonathan 4
Accession 0001209191-22-016388
CIK 0001610950other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:09 PM ET
Size
10.5 KB
Accession
0001209191-22-016388
Insider Transaction Report
Form 4
Olefson Jonathan
General Counsel & Corp Secty
Transactions
- Award
Class A Common Stock
2022-03-02+1,126→ 30,008 total - Award
Class A Common Stock
2022-03-02+5,705→ 28,882 total - Award
Class A Common Stock
2022-03-02+1,599→ 31,607 total - Tax Payment
Class A Common Stock
2022-03-02$80.75/sh−4,100$331,075→ 27,507 total
Footnotes (4)
- [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
- [F2]Includes 267 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
- [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
- [F4]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.
Documents
Issuer
Syneos Health, Inc.
CIK 0001610950
Entity typeother
Related Parties
1- filerCIK 0001673025
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:09 PM ET
- Size
- 10.5 KB